文献速递肾癌与肾肿瘤

如何选择肾肿块活检的最佳候选者

How to Select the Optimal Candidates for Renal Mass Biopsy.
PubMed 文献 · Eur Urol Oncol · 2020-10-21

该研究基于2252例cT1N0M0肾肿块患者数据,建立年龄与肿瘤大小的交互模型预测恶性组织学,并按性别分层。模型在决策曲线分析中显示临床效用,预测恶性概率男性<55%、女性<60%时建议活检,高于此值可直接手术。

要点

  • 年龄和肿瘤大小均为恶性组织学的预测因子,且存在显著交互作用。
  • 男性恶性概率<55%、女性<60%时建议行肾活检以避免过度治疗。
  • 该模型比单独使用肿瘤大小更具信息量,后者是目前主动监测的唯一绝对标准。

核心结论

  • 基于年龄、肾肿块大小及其交互作用的模型可预测恶性组织学,并指导活检与直接手术的选择。
  • 低概率患者应考虑肾活检,高概率患者可直接手术,以减少过度治疗。

研究设计与样本

  • 回顾性分析2252例cT1N0M0肾肿块患者数据,其中男性1551例(69%)、女性701例(31%)。
  • 采用逻辑回归建立年龄与肿瘤大小的交互模型,并按性别分层分析。

主要发现

  • 逻辑回归显示年龄和肾肿块大小均为恶性组织学的预测因子。
  • 男性年龄OR为1.82(95%CI 1.78-2.80),肿瘤大小OR为2.04(95%CI 1.69-2.47);女性相同(均p≤0.007)。
  • 年龄与肿瘤大小之间存在显著的连续-连续交互作用(p<0.001)。
  • 决策曲线分析显示模型在男性预测恶性概率<55%、女性<60%时具有临床效用。

关键数值与推荐

  • 男性预测恶性概率<55%时建议肾活检,≥55%可考虑直接手术。
  • 女性预测恶性概率<60%时建议肾活检,≥60%可考虑直接手术。
  • 模型比单独使用肿瘤大小更具信息量,后者是目前主动监测的唯一绝对标准。

临床怎么用

  • 临床可依据患者年龄、肾肿块大小及性别计算恶性概率,指导活检或直接手术决策。
  • 对低概率患者行肾活检有助于避免良性肿瘤的过度手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Surgical treatment of small renal masses (RMs) is still characterized by a non-negligible rate of benign histology, ultimately resulting in overtreatment. Since the risk of kidney cancer increases with age and the risk of malignancy usually increases with tumor size, we created a model based on patient age, RM size, and their interaction for predicting malignant histology. As male sex is associated with a higher risk of renal malignancy, we also stratified our analyses by sex. We used data for 2252 patients with cT1N0M0 disease (1551 male [69%], 701 female [31%]). On logistic regression, both age and RM size were predictors of malignant histology. For males, the odds ratio (OR) was 1.82 (95% confidence interval [CI] 1.78-2.80) for age and 2.04 (95% CI 1.69-2.47) for RM size; for females, the OR was 1.82 (95% CI 1.78-2.80) for age and 2.04 (95% CI 1.69-2.47) for RM size (all p ≤ 0.007), with a significant continuous-by-continuous interaction between them (p < 0.001) in both models. On decision curve analysis, the model demonstrated clinical utility for predicting malignancy at a probability of <55% for males and <60% for females. Individuals with lower probability should be considered for renal biopsy and those with higher probability for upfront surgery. The model was also more informative than RM size alone in predicting malignancy, which currently represents the only absolute criterion for active surveillance eligibility. PATIENT SUMMARY: In this study we analyzed the correlation between age and tumor size for predicting tumor malignancy. The aim in management is to balance the utility of performing a biopsy and the appropriateness of upfront surgery against the ultimate goal of decreasing overtreatment.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Martini A, Larcher A, Bravi CA, et al. How to Select the Optimal Candidates for Renal Mass Biopsy. Eur Urol Oncol. 2020. PMID: 34074486. doi:10.1016/j.euo.2020.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。